CAS No.: 931399-19-8
GSK360A Catalog No. CSN20613
Synonyms: GSK-1120360A
GSK360A is an active HIF-PHD inhibitor with systemic and local effects by stabilizing HIF-1α signaling and can improve long-term ventricular function.
| 规格 | 价格 | 促销价格 | 库存 | 数量 |
|---|
400-920-2911
sales@csnpharm.cn
tech@csnpharm.cn
纯度 & 质量文件
批次:
靶点选择性
生物活性
- 描述
- 参考文献
- [1] Ong SG, Lee WH, et al. HIF-1 reduces ischaemia-reperfusion injury in the heart by targeting the mitochondrial permeability transition pore. Cardiovasc Res. 2014 Oct 1;104(1):24-36.
- [2] Bao W, Qin P, et al. Chronic inhibition of hypoxia-inducible factor prolyl 4-hydroxylase improves ventricular performance, remodeling, and vascularity after myocardial infarction in the rat. J Cardiovasc Pharmacol. 2010 Aug;56(2):147-55.
实验方案
- 计算器
- 储存液制备
技术信息
| CAS号 | 931399-19-8 | 储存条件 |
|
|
| 分子式 | C17H17FN2O5 | 运输 | 蓝冰 | |
| 分子量 | 348.33 | 别名 | GSK-1120360A |
